CTOs on the Move

Volpara Health

www.volpara.com

 
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.volpara.com
  • 19000 33rd Avenue W Suite 130
    Lynnwood, WA USA 98036
  • Phone: 800.305.3865

Executives

Name Title Contact Details

Similar Companies

Essential Group

Essential Group, Inc is a Gurnee, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarasota Orthopedic Associates

Sarasota Orthopedic Associates has served the community for more than 40 years and is one of the most highly respected orthopedic groups in Florida. Our group of esteemed physicians are sought out for their medical and technical expertise. Sarasota Orthopedic Associates provides quality orthopedic treatment and care to thousands of patients each year.

Unistrut Corporation a division of Tyco

Unistrut Corporation a division of Tyco is a Wayne, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valeo Health Systems

Valeo Health Systems is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gynesonics

At Gynesonics our mission is to design and develop new and advanced technologies for improving women`s health. We are focused on providing an incision-free option to women and the physicians who care for them, in treating symptomatic uterine fibroids. We are initiating a pivotal IDE trial in the United States to verify the safety and efficacy of the Sonata system, in preserving the uterus while treating those fibroids associated with abnormal uterine bleeding that are difficult to treat with existing technology and surgical techniques. We are committed to providing women with a safe and effective incision-free alternative to the invasive surgical techniques of hysterectomy or myomectomy for their severe menstrual symptoms associated with fibroids.